HU-308 is a potent, highly selective synthetic cannabinoid receptor 2 (CB2) agonist primarily utilized in pharmacological research for its potential anti-inflammatory and analgesic properties. In pharmaceutical… Read more
HU-308 is a potent, highly selective synthetic cannabinoid receptor 2 (CB2) agonist primarily utilized in pharmacological research for its potential anti-inflammatory and analgesic properties. In pharmaceutical development and analytical chemistry, high-quality reference standards are essential to ensure the precision of data derived from this compound. Laboratories rely on a comprehensive range of related materials, including synthesized impurities and metabolic degradation products, to facilitate accurate impurity profiling during drug development and stability testing. Furthermore, the inclusion of stable isotope labelled compounds allows for the precise quantification of the drug and its metabolites within complex matrices, serving as vital internal standards for method validation and rigorous quality control in bioanalytical assays. These analytical tools ensure consistency and reliability when investigating the pharmacological effects of CB2 receptor activation in preclinical models.